294 related articles for article (PubMed ID: 18823681)
21. Expression of myogenic regulatory factors and myo-endothelial remodeling in sporadic inclusion body myositis.
Wanschitz JV; Dubourg O; Lacene E; Fischer MB; Höftberger R; Budka H; Romero NB; Eymard B; Herson S; Butler-Browne GS; Voit T; Benveniste O
Neuromuscul Disord; 2013 Jan; 23(1):75-83. PubMed ID: 23058947
[TBL] [Abstract][Full Text] [Related]
22. Plasma cells in muscle in inclusion body myositis and polymyositis.
Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
[TBL] [Abstract][Full Text] [Related]
23. Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1.
Thornell LE; Lindstöm M; Renault V; Klein A; Mouly V; Ansved T; Butler-Browne G; Furling D
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):603-13. PubMed ID: 19207265
[TBL] [Abstract][Full Text] [Related]
24. Inclusion body myopathy associated with motor neuron syndrome: three case reports.
Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G
Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783
[TBL] [Abstract][Full Text] [Related]
25. Decreased SIRT1 deacetylase activity in sporadic inclusion-body myositis muscle fibers.
Nogalska A; D'Agostino C; Engel WK; Davies KJ; Askanas V
Neurobiol Aging; 2010 Sep; 31(9):1637-48. PubMed ID: 18922603
[TBL] [Abstract][Full Text] [Related]
26. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
[TBL] [Abstract][Full Text] [Related]
27. Inclusion-body myositis: a myodegenerative conformational disorder associated with Abeta, protein misfolding, and proteasome inhibition.
Askanas V; Engel WK
Neurology; 2006 Jan; 66(2 Suppl 1):S39-48. PubMed ID: 16432144
[TBL] [Abstract][Full Text] [Related]
28. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
[TBL] [Abstract][Full Text] [Related]
29. Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.
Nogalska A; D'Agostino C; Engel WK; Cacciottolo M; Asada S; Mori K; Askanas V
J Neuropathol Exp Neurol; 2015 Jun; 74(6):538-46. PubMed ID: 25978849
[TBL] [Abstract][Full Text] [Related]
30. Familial inflammatory inclusion body myositis.
Ranque-Francois B; Maisonobe T; Dion E; Piette JC; Chauveheid MP; Amoura Z; Papo T
Ann Rheum Dis; 2005 Apr; 64(4):634-7. PubMed ID: 15769920
[TBL] [Abstract][Full Text] [Related]
31. Single-fiber electromyography in sporadic inclusion body myopathy.
Hatanaka Y; Oh SJ
Clin Neurophysiol; 2007 Jul; 118(7):1563-8. PubMed ID: 17507289
[TBL] [Abstract][Full Text] [Related]
32. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies.
Maurage CA; Bussière T; Sergeant N; Ghesteem A; Figarella-Branger D; Ruchoux MM; Pellissier JF; Delacourte A
Neuropathol Appl Neurobiol; 2004 Dec; 30(6):624-34. PubMed ID: 15541003
[TBL] [Abstract][Full Text] [Related]
33. Raised troponin T in inclusion body myositis is common and serum levels are persistent over time.
Lindberg C; Klintberg L; Oldfors A
Neuromuscul Disord; 2006 Aug; 16(8):495-7. PubMed ID: 16920359
[TBL] [Abstract][Full Text] [Related]
34. Inclusion body myositis and paraproteinemia: incidence and immunopathologic correlations.
Dalakas MC; Illa I; Gallardo E; Juarez C
Ann Neurol; 1997 Jan; 41(1):100-4. PubMed ID: 9005871
[TBL] [Abstract][Full Text] [Related]
35. Amyloid-beta42 is preferentially accumulated in muscle fibers of patients with sporadic inclusion-body myositis.
Vattemi G; Nogalska A; King Engel W; D'Agostino C; Checler F; Askanas V
Acta Neuropathol; 2009 May; 117(5):569-74. PubMed ID: 19280202
[TBL] [Abstract][Full Text] [Related]
36. Inclusion-body myositis, a multifactorial muscle disease associated with aging: current concepts of pathogenesis.
Askanas V; Engel WK
Curr Opin Rheumatol; 2007 Nov; 19(6):550-9. PubMed ID: 17917534
[TBL] [Abstract][Full Text] [Related]
37. Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle.
Broccolini A; Gidaro T; De Cristofaro R; Morosetti R; Gliubizzi C; Ricci E; Tonali PA; Mirabella M
J Neurochem; 2008 May; 105(3):971-81. PubMed ID: 18182043
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial abnormalities in inclusion-body myositis.
Oldfors A; Moslemi AR; Jonasson L; Ohlsson M; Kollberg G; Lindberg C
Neurology; 2006 Jan; 66(2 Suppl 1):S49-55. PubMed ID: 16432145
[TBL] [Abstract][Full Text] [Related]
39. Molecular pathology and pathogenesis of inclusion-body myositis.
Askanas V; Engel WK
Microsc Res Tech; 2005 Jul; 67(3-4):114-20. PubMed ID: 16104000
[TBL] [Abstract][Full Text] [Related]
40. Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies.
Mirabella M; Alvarez RB; Bilak M; Engel WK; Askanas V
J Neuropathol Exp Neurol; 1996 Jul; 55(7):774-86. PubMed ID: 8965093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
